Literature DB >> 16249550

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

Earl S Ford1.   

Abstract

OBJECTIVE: The International Diabetes Federation (IDF) has proposed a new definition of the metabolic syndrome that emphasizes central adiposity as determined by ethnic group-specific thresholds of waist circumference. The objective of this study was to estimate the prevalence of this syndrome using the IDF definition among U.S. adults and to compare it with the prevalence estimated using the definition of the National Cholesterol Education Program (NCEP). RESEARCH DESIGN AND METHODS: A total of 3,601 men and women aged > or =20 years from the National Health and Nutrition Examination Survey 1999-2002 were included in the analyses.
RESULTS: Based on the NCEP definition, the unadjusted prevalence of the metabolic syndrome was 34.5 +/- 0.9% (percent +/- SE) among all participants, 33.7 +/- 1.6% among men, and 35.4 +/- 1.2% among women. Based on the IDF definition, the unadjusted prevalence of the metabolic syndrome was 39.0 +/- 1.1% among all participants, 39.9 +/- 1.7% among men, and 38.1 +/- 1.2% among women. The IDF definition led to higher estimates of prevalence in all of the demographic groups, especially among Mexican-American men. The two definitions similarly classified approximately 93% of the participants as having or not having the metabolic syndrome.
CONCLUSIONS: In the U.S., the use of the IDF definition of the metabolic syndrome leads to a higher prevalence estimate of the metabolic syndrome than the estimate based on the NCEP definition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249550     DOI: 10.2337/diacare.28.11.2745

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  327 in total

1.  Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.

Authors:  Raj S Padwal; Arya M Sharma
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

2.  APAP impact on metabolic syndrome in obstructive sleep apnea patients.

Authors:  Patrícia Caetano Mota; Marta Drummond; João Carlos Winck; Ana Cristina Santos; João Almeida; José Agostinho Marques
Journal:  Sleep Breath       Date:  2010-09-24       Impact factor: 2.816

3.  Differential fatty acid profile in adipose and non-adipose tissues in obese mice.

Authors:  Mengting Li; Weisi Fu; Xiang-An Li
Journal:  Int J Clin Exp Med       Date:  2010-09-27

4.  β-Cell dysfunction is associated with metabolic syndrome severity in adults.

Authors:  Steven K Malin; Stephen Finnegan; Ciaran E Fealy; Julianne Filion; Michael B Rocco; John P Kirwan
Journal:  Metab Syndr Relat Disord       Date:  2013-11-27       Impact factor: 1.894

5.  Cardiovascular Disease Risk Among Older Immigrants in the United States: A Comparison of Risk Measures.

Authors:  Tina R Sadarangani; Deborah Chyun; Chau Trinh-Shevrin; Gary Yu; Christine Kovner
Journal:  J Cardiovasc Nurs       Date:  2018 Nov/Dec       Impact factor: 2.083

Review 6.  Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment.

Authors:  Jordan Gaines; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2018-09-03       Impact factor: 11.609

Review 7.  [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].

Authors:  S C Bischoff
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

8.  Smaller hip circumference is associated with dyslipidemia and the metabolic syndrome in obese women.

Authors:  John B Dixon; Boyd J G Strauss; Cheryl Laurie; Paul E O'Brien
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

Review 9.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

10.  Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome?

Authors:  Hong Truong; Julia R DiBello; Edward Ruiz-Narvaez; Peter Kraft; Hannia Campos; Ana Baylin
Journal:  Am J Clin Nutr       Date:  2009-01-14       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.